Elisaf MS - Search Results

1

Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.

Pappa E, Rizos CV, Filippatos TD, Elisaf MS. Pappa E, et al. Among authors: elisaf ms. J Cardiovasc Pharmacol Ther. 2019 Jul;24(4):315-322. doi: 10.1177/1074248419838506. Epub 2019 Mar 25. J Cardiovasc Pharmacol Ther. 2019. PMID: 30909733 Review.

2

Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.

Liamis G, Kakafika A, Bairaktari E, Miltiadous G, Tsimihodimos V, Goudevenos J, Achimastos A, Elisaf M. Liamis G, et al. Curr Med Res Opin. 2002;18(3):125-8. doi: 10.1185/030079902125000372. Curr Med Res Opin. 2002. PMID: 12094821 Clinical Trial.

3

Effects of fibrates on serum metabolic parameters.

Elisaf M. Elisaf M. Curr Med Res Opin. 2002;18(5):269-76. doi: 10.1185/030079902125000516. Curr Med Res Opin. 2002. PMID: 12240789 Review.

4

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.

Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Rizos E, et al. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):219-26. doi: 10.1177/107424840200700404. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490967 Clinical Trial.

5

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.

Rizos E, Bairaktari E, Kostoula A, Hasiotis G, Achimastos A, Ganotakis E, Elisaf M, Mikhailidis DP. Rizos E, et al. J Cardiovasc Pharmacol Ther. 2003 Jun;8(2):127-34. doi: 10.1177/107424840300800206. J Cardiovasc Pharmacol Ther. 2003. PMID: 12808486 Clinical Trial.

6

Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIB.

Tsimihodimos V, Karabina SA, Tambaki A, Bairaktari E, Achimastos A, Tselepis A, Elisaf M. Tsimihodimos V, et al. J Cardiovasc Pharmacol. 2003 Aug;42(2):304-10. doi: 10.1097/00005344-200308000-00021. J Cardiovasc Pharmacol. 2003. PMID: 12883336 Review.

7

Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.

Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. J Clin Pharmacol. 2003 Aug;43(8):825-30. doi: 10.1177/0091270003255920. J Clin Pharmacol. 2003. PMID: 12953339 Clinical Trial.

8

Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values.

Tsimihodimos V, Kostoula A, Kakafika A, Bairaktari E, Tselepis AD, Mikhailidis DP, Elisaf M. Tsimihodimos V, et al. J Cardiovasc Pharmacol Ther. 2004 Mar;9(1):27-33. doi: 10.1177/107424840400900i105. J Cardiovasc Pharmacol Ther. 2004. PMID: 15094966 Clinical Trial.

9

Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.

Tambaki AP, Rizos E, Tsimihodimos V, Tselepis AD, Elisaf M. Tambaki AP, et al. J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):91-5. doi: 10.1177/107424840400900204. J Cardiovasc Pharmacol Ther. 2004. PMID: 15309245

10

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

Bairaktari ET, Seferiadis KI, Elisaf MS. Bairaktari ET, et al. Among authors: elisaf ms. J Cardiovasc Pharmacol Ther. 2005 Mar;10(1):45-54. doi: 10.1177/107424840501000106. J Cardiovasc Pharmacol Ther. 2005. PMID: 15821838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page